SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Satoh, M.
Right arrow Articles by Homma, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Satoh, M.
Right arrow Articles by Homma, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Autoimmune Diseases
*Joint Disorders
*Salivary Gland Disorders
*Sjogren's Syndrome
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Late development of anti-La/SS-B antibodies in a patient with Sjogren's syndrome and high titer anti-Ro/SS-A antibodies

M. Satoh

Division of Rheumatology and Immunology, Departments of Medicine, and Microbiology and Immunology, the Thurston Arthritis Research Center and Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7280, USA

KJ Hamilton

Division of Rheumatology and Immunology, Departments of Medicine, and Microbiology and Immunology, the Thurston Arthritis Research Center and Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7280, USA

JJ Langdon

Division of Rheumatology and Immunology, Departments of Medicine, and Microbiology and Immunology, the Thurston Arthritis Research Center and Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7280, USA

M. Akizuki

Department of Internal Medicine, Keio University School of Medicine, Tokyo, 160, Japan

H. Yamagata

Department of Internal Medicine, National Murayama Hospital, Tokyo, 208, Japan

S. Nakayama

Department of Internal Medicine, National Murayama Hospital, Tokyo, 208, Japan

WH Reeves

Division of Rheumatology and Immunology, Departments of Medicine, and Microbiology and Immunology, the Thurston Arthritis Research Center and Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7280, USA

M. Homma

Department of Internal Medicine, Keio University School of Medicine, Tokyo, 160, Japan

The frequent coexistence of anti-Ro and anti-La autoantibodies is well described, however, there is little evidence of sequential development of these two autoantibodies. We report a case of typical Sjogren's syndrome with high titer anti-Ro antibodies, who subsequently developed anti-La antibodies later in the course. This case suggests that the anti-La anti bodies may actually follow the anti-Ro antibodies in some cases as hypothesized in the concept of linked set of autoantibodies, analogous to development of anti-Sm in certain anti-nRNP antibody positive SLE patients and animal models.

Key Words: anti-La antibodies • anti-Ro antibodies • Sjogren's syndrome • antinuclear anti bodies

Lupus, Vol. 5, No. 4, 337-339 (1996)
DOI: 10.1177/096120339600500417


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement